Why Trump catching COVID-19 could actually be a good thing for ASX shares

News that the US President caught COVID-19 roiled global markets, but the shakeup is likely to be good thing for ASX stock investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

News that the US President caught COVID-19 roiled global markets, but the shakeup is likely to be good thing for ASX stock investors.

That might sound somewhat contradictory when Donald Trump's infection sent the S&P/ASX 200 Index (Index:^AXJO) tumbling 1.4% on Friday. The S&P 500 Index subsequently lost 1% of its value too.

The sell-off is understandable. Markets hate uncertainty and with Trump being taken to hospital, questions about how the world's most powerful economy will operate and the impact on the upcoming election are up in the air.

Buy stocks when US president's health is at risk

But history shows us that any market weakness from US presidents' health issues are fleeting and relatively shallow.

Even when Ronald Raegan was shot in an attempted assassination on 30 March 1981, the S&P 500 only caught a hiccup.

Moreover, Trump's coronavirus misadventure may actually be a positive for share markets.

How Trump catching COVID can help stocks

For one, the medical emergency may put more pressure on the Democrats and Republicans to strike a new stimulus deal.

Markets have been anxiously waiting for a fresh round of government support but both parties have so far failed to reach a compromise.

This might now change as the severity of the situation is brought to the forefront, reported Bloomberg.

The other side-effect from Trump's COVID run in is that it might be enough to give presidential contender Joe Biden a clear lead.

Why a clean Biden win will trigger a market rally

Some think Republican presidents are better for equity markets than a Democrat leader, but that's a myth.

What will hurt investors is a close election where the outcome isn't known for days, if not weeks. The stakes are increased this time as Trump said he won't leave the Oval Office willingly. The only way to get him out with little fuss is if the ballots are undeniably in Biden's favour.

However, the next few weeks are likely to be a volatile period for investors due to disinformation – and this isn't because of Trump's tenuous relationship with the truth.

Expect more market volatility and disinformation

US Presidents have a tradition of hiding their medical condition from the public, lawmakers and even their own administration.

A few examples include Grover Cleveland, Franklin D. Roosevelt and Dwight D. Eisenhower, according to the Washington Post.

The White House says that Trump only has minor symptoms, like a mild fever, and that his admission to hospital is only a "precaution".

How safe is Trump?

But I doubt Trump would allow himself to be taken to hospital for only a mild fever. That doesn't gel with the strongman image he likes to portray.

Also, you don't use an experimental (read unproven) drug on a sitting president unless you really needed to.

I suspect Trump may be in worse shape than what his administration is saying. But don't expect any clarity on this till well after the November election.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. Connect with me on Twitter @brenlau.

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

These top ASX 200 shares could rise 30% to 40%

Analysts are predicting big things from these shares. Let's find out why.

Read more »

Stacks of coins in a row with each higher than the last, and a person standing on top of each one watching them grow.
Dividend Investing

How I'd invest $2,000 in high-yield ASX 300 shares

I rate these businesses as strong buys for the long-term.

Read more »

A rueful woman tucks into a sweet pie as she contemplates a decision with regret.
Share Fallers

The worst 4 ASX 200 stocks to buy and hold in April unmasked

Investors sent these four ASX 200 stocks tumbling 21% to 44% in April.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Share Fallers

Why these top ASX shares sank 10%+ in April

It was a tough month for these popular shares.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Netwealth, PLS, and Reliance shares

Morgans has given its verdict on these shares. Let's see what the broker is saying.

Read more »

Two smiling men in high visibility vests and yellow hardhats stand side by side with a large mound of earth and mining equipment behind them smiling as the Carnaby Resources share price rises today
Share Market News

Buy, hold, sell: Capricorn Metals, PLS Group, Fortescue shares

Bell Potter has reviewed its ratings and 12-month price targets on three ASX 200 mining shares.

Read more »

A group of young people celebrate and party outside.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors finally caught a break this Friday.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »